Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Optimizing mesenchymal stromal cell-based therapies to treat neonatal lung injury
EF 2023-24
Résumé
Bronchopulmonary dysplasia (BPD) is the most common and severe lung condition in babies born extremely prematurely (24-28 weeks of gestation instead of 40). These babies need artificial breathing and oxygen therapy to help them breathe. However, these treatments can also damage their lungs, stopping the growth of air sacs and leading to long term problems beyond childhood. There is no cure for BPD. Stem cells are special cells that can develop into different types of cells such as muscle or brain cells. Stem cells are present in many parts of our body, including the umbilical cord, which is discarded at birth. Our lab has shown that stem cells repair the lung and stimulate its growth in newborn rats exposed to oxygen, a BPD model. Other studies have demonstrated that stem cells release small packages carrying messages to help with repairing the lung. However, there are different types of stem cells and some may be better at repairing than others. Advancements in reprogramming a cell's identity have allowed us to convert any adult cell in the human body into stem cells in the lab. Stem cells generated in the lab are more similar to each other. In this study, we will test two approaches to find a cure for BPD: First, we will compare the lung-healing effect of stem cells generated in the lab to stem cells taken from the umbilical cord. Second, we will test the lung-healing effect of the small packages released by these stem cells. These packages may offer a safer treatment when compared to their parent cells as they are at a lower risk of rejection by the immune system and forming tumors. This study will help unveil a new safe and effective treatment to save preterm children suffering from BPD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506031
Name
Fawagreh Celine K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Optimizing mesenchymal stromal cell-based therapies to treat neonatal lung injury
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bronchopulmonary Dysplasia; Extracellular Vesicles; Hyperoxia; Ipsc-Induced Mesenchymal Stromal Cells; Lung Function; Lung Structure; Mesenchymal Stromal Cell Heterogeneity; Mesenchymal Stromal Cells; Tangential Flow Filtration; Therapeutic Effect
Abstract
Bronchopulmonary dysplasia (BPD) is the most common and severe lung condition in babies born extremely prematurely (24-28 weeks of gestation instead of 40). These babies need artificial breathing and oxygen therapy to help them breathe. However, these treatments can also damage their lungs, stopping the growth of air sacs and leading to long term problems beyond childhood. There is no cure for BPD. Stem cells are special cells that can develop into different types of cells such as muscle or brain cells. Stem cells are present in many parts of our body, including the umbilical cord, which is discarded at birth. Our lab has shown that stem cells repair the lung and stimulate its growth in newborn rats exposed to oxygen, a BPD model. Other studies have demonstrated that stem cells release small packages carrying messages to help with repairing the lung. However, there are different types of stem cells and some may be better at repairing than others. Advancements in reprogramming a cell's identity have allowed us to convert any adult cell in the human body into stem cells in the lab. Stem cells generated in the lab are more similar to each other. In this study, we will test two approaches to find a cure for BPD: First, we will compare the lung-healing effect of stem cells generated in the lab to stem cells taken from the umbilical cord. Second, we will test the lung-healing effect of the small packages released by these stem cells. These packages may offer a safer treatment when compared to their parent cells as they are at a lower risk of rejection by the immune system and forming tumors. This study will help unveil a new safe and effective treatment to save preterm children suffering from BPD.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fawagreh, Celine K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~